(Q44622923)

reason for preferred rank

4 December 2017

title

Extended in Vivo Pharmacodynamic Activity of E5564 in Normal Volunteers with Experimental Endotoxemia (English)

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

22 March 2024

Extended in vivo pharmacodynamic activity of E5564 in normal volunteers with experimental endotoxemia [corrected] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14566003

22 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

22 March 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

22 March 2024

1 reference

11

Kishor M Wasan

1 reference

4 December 2017

Melvyn Lynn

1

1 reference

4 December 2017

Robert Noveck

6

1 reference

4 December 2017

Ramon Vargas

7

1 reference

4 December 2017

Tony D'Angelo

8

1 reference

4 December 2017

Sandra Gotzkowsky

9

1 reference

4 December 2017

Y. Nancy Wong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14566003

22 March 2024

Janice L. Wheeler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14566003

22 March 2024

Richard J. Kao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14566003

22 March 2024

Carlos A. Perdomo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14566003

22 March 2024

F. Gilbert McMahon

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14566003

22 March 2024

Daniel P. Rossignol

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14566003

22 March 2024

language of work or name

English

0 references

publication date

17 October 2003

1 reference

full work available at URL

4 December 2017

https://syndication.highwire.org/content/doi/10.1124/jpet.103.056531

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

Journal of Pharmacology and Experimental Therapeutics

22 March 2024

published in

1 reference

4 December 2017

volume

308

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

175-181

1 reference

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

4 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

Endotoxemia in human septic shock

22 March 2024

4

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients

22 March 2024

5

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

Properties of US Standard Endotoxin (EC-5) in human male volunteers

22 March 2024

6

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia

22 March 2024

7

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist

22 March 2024

9

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock

22 March 2024

10

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

Pathogenetic mechanisms of septic shock

22 March 2024

11

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy

22 March 2024

12

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

Inhibition of cyclo-oxygenase attenuates the metabolic response to endotoxin in humans

22 March 2024

13

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

Effects ofin vivo endotoxin infusions onin vitro cellular immune responses in humans

22 March 2024

14

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteins

22 March 2024

15

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

The cardiovascular response of normal humans to the administration of endotoxin.

22 March 2024

18

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects

22 March 2024

19

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin

22 March 2024

21

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein.

22 March 2024

22

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

Association of the endotoxin antagonist E5564 with high-density lipoproteins in vitro: dependence on low-density and triglyceride-rich lipoprotein concentrations

22 March 2024

23

1 reference

https://api.crossref.org/works/10.1124/JPET.103.056531

22 March 2024

Identifiers

1 reference

4 December 2017

1 reference